Landscapes / Companies
Crinetics Pharmaceuticals Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
3
in active trials · 4 in all
Trials
5 active
16 since 2021
Drugs3
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Approved | Aug 2027Phase 3 trial completes | |||
| Next date | Aug 2027 · Phase 3 trial completes | ||||
| Also tested for | Carcinoid Syndrome, Carcinoid and 7 more | ||||
| Open drug page | |||||
— |
Phase 3 | May 2027Phase 3 trial completes | |||
| Next date | May 2027 · Phase 3 trial completes | ||||
| Also tested for | Congenital Adrenal Hyperplasia, Classic Congenital Adrenal Hyperplasia | ||||
| Open drug page | |||||
— |
Phase 1/2 | Aug 2027Phase 1/2 trial completes | |||
| Next date | Aug 2027 · Phase 1/2 trial completes | ||||
| Also tested for | SST2-positive Neuroendocrine Neoplasms, Neuroendocrine Tumors and 1 more | ||||
| Open drug page | |||||
About
- No active trial
- Randomized
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021